IL118369A - (2R)-1-¬3,5-bis(trifluoromethyl)benzoyl¾-2-(1H-indol-3-YL-methyl)-4-¬N-(4-methyl-1-piperazinyl)carbamoylmethyl¾-piperazine processes for its preparation and pharmaceutical compositions containing same - Google Patents
(2R)-1-¬3,5-bis(trifluoromethyl)benzoyl¾-2-(1H-indol-3-YL-methyl)-4-¬N-(4-methyl-1-piperazinyl)carbamoylmethyl¾-piperazine processes for its preparation and pharmaceutical compositions containing sameInfo
- Publication number
- IL118369A IL118369A IL11836996A IL11836996A IL118369A IL 118369 A IL118369 A IL 118369A IL 11836996 A IL11836996 A IL 11836996A IL 11836996 A IL11836996 A IL 11836996A IL 118369 A IL118369 A IL 118369A
- Authority
- IL
- Israel
- Prior art keywords
- methyl
- indol
- piperazinyl
- piperazine
- trifluoromethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45017695A | 1995-05-25 | 1995-05-25 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL118369A0 IL118369A0 (en) | 1996-09-12 |
| IL118369A true IL118369A (en) | 2000-06-01 |
Family
ID=23787083
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL11836996A IL118369A (en) | 1995-05-25 | 1996-05-22 | (2R)-1-¬3,5-bis(trifluoromethyl)benzoyl¾-2-(1H-indol-3-YL-methyl)-4-¬N-(4-methyl-1-piperazinyl)carbamoylmethyl¾-piperazine processes for its preparation and pharmaceutical compositions containing same |
Country Status (14)
| Country | Link |
|---|---|
| EP (1) | EP0846116A1 (en) |
| JP (1) | JP3071829B2 (en) |
| KR (1) | KR19990021857A (en) |
| CN (1) | CN1072220C (en) |
| AU (1) | AU706021B2 (en) |
| CA (1) | CA2222041A1 (en) |
| EA (1) | EA000669B1 (en) |
| HU (1) | HUP9900822A3 (en) |
| IL (1) | IL118369A (en) |
| NZ (1) | NZ307625A (en) |
| TR (1) | TR199600438A2 (en) |
| TW (1) | TW391960B (en) |
| WO (1) | WO1996037489A1 (en) |
| ZA (1) | ZA964101B (en) |
Families Citing this family (47)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2189501A1 (en) * | 1995-11-06 | 1997-05-07 | Harry R. Howard | Nk-1 receptor antagonists for the treatment of cancer |
| ES2175161T3 (en) * | 1995-12-18 | 2002-11-16 | Fujisawa Pharmaceutical Co | PIPERAZINE DERIVATIVES AS TAQUIQUININE ANTAGONISTS. |
| AUPO735997A0 (en) | 1997-06-17 | 1997-07-10 | Fujisawa Pharmaceutical Co., Ltd. | Piperazine derivatives |
| DE19824865A1 (en) * | 1997-08-27 | 1999-03-04 | Solvay Pharm Gmbh | New urea derivatives |
| DE59814233D1 (en) * | 1997-08-27 | 2008-07-03 | Solvay Pharm Gmbh | Indolmethyl-N, N'-bisacylpiperazines as neurokinin receptor antagonists |
| US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
| DE10036818A1 (en) * | 2000-07-28 | 2002-02-07 | Solvay Pharm Gmbh | New N-Triazolylmethyl-Piperazine Derivatives as Neurokinin Receptor Antagonists |
| UA75425C2 (en) * | 2001-07-09 | 2006-04-17 | Piperazine oxime derivatives with antagonistic activity to nk-1 receptor, use thereof, a pharmaceutical composition based thereon, a method for producing and a method for producing intermediary compounds | |
| UA77515C2 (en) | 2002-04-04 | 2006-12-15 | Diazabicyclo alkane derivatives possessing neuroldnin-nk1 receptor antagonistic activity | |
| ZA200701232B (en) | 2004-07-15 | 2008-08-27 | Amr Technology Inc | Aryl-and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin |
| ES2382814T3 (en) | 2005-05-17 | 2012-06-13 | Merck Sharp & Dohme Ltd. | Cis-4 - [(4-chlorophenyl) sulfonyl] -4- (2,5-difluorophenyl) cyclohexanopropanoic acid for cancer treatment |
| EP1904069B1 (en) | 2005-07-15 | 2018-06-13 | Albany Molecular Research, Inc. | Aryl-and heteroaryl-substituted tetrahydrobenzazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin |
| US8293900B2 (en) | 2005-09-29 | 2012-10-23 | Merck Sharp & Dohme Corp | Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators |
| GB0603041D0 (en) | 2006-02-15 | 2006-03-29 | Angeletti P Ist Richerche Bio | Therapeutic compounds |
| CA2664113C (en) | 2006-09-22 | 2013-05-28 | Merck & Co., Inc. | Use of platencin and platensimycin as fatty acid synthesis inhibitors to treat obesity, diabetes and cancer |
| US20110218176A1 (en) | 2006-11-01 | 2011-09-08 | Barbara Brooke Jennings-Spring | Compounds, methods, and treatments for abnormal signaling pathways for prenatal and postnatal development |
| BRPI0806245B1 (en) | 2007-01-10 | 2022-01-25 | Msd Italia S.R.L. | Compounds of formula i and their uses |
| KR20090112722A (en) | 2007-01-24 | 2009-10-28 | 글락소 그룹 리미티드 | Pharmaceutical compositions comprising 3,5-diamino-6-2,3-dichl0rophenyl-1,2,4-triazine or r--2,4-diamino-5-2,3-dichlorophenyl-6-fluoromethyl pyrimidine and an nk1 |
| CA2682727C (en) | 2007-04-02 | 2016-03-22 | Banyu Pharmaceutical Co., Ltd. | Indoledione derivative |
| WO2008147864A2 (en) * | 2007-05-22 | 2008-12-04 | Xenon Pharmaceuticals Inc. | Methods of using piperazine compounds in treating sodium channel-mediated diseases or conditions |
| EP2170076B1 (en) | 2007-06-27 | 2016-05-18 | Merck Sharp & Dohme Corp. | 4-carboxybenzylamino derivatives as histone deacetylase inhibitors |
| US8598184B2 (en) | 2008-03-03 | 2013-12-03 | Tiger Pharmatech | Protein kinase inhibitors |
| US9156812B2 (en) | 2008-06-04 | 2015-10-13 | Bristol-Myers Squibb Company | Crystalline form of 6-[(4S)-2-methyl-4-(2-naphthyl)-1,2,3,4-tetrahydroisoquinolin-7-yl]pyridazin-3-amine |
| US8691825B2 (en) | 2009-04-01 | 2014-04-08 | Merck Sharp & Dohme Corp. | Inhibitors of AKT activity |
| KR20120034644A (en) | 2009-05-12 | 2012-04-12 | 알바니 몰레큘라 리써치, 인크. | Aryl, heteroaryl, and heterocycle substituted tetrahydroisoquinolines and use thereof |
| CN102638982B (en) | 2009-05-12 | 2015-07-08 | 百时美施贵宝公司 | Crystalline forms of (s)-7-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-4-(3,4-dichlorohphenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| CA2760837C (en) | 2009-05-12 | 2018-04-03 | Albany Molecular Research, Inc. | 7-([1,2,4]triazolo[1,5-.alpha.]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof |
| WO2011046771A1 (en) | 2009-10-14 | 2011-04-21 | Schering Corporation | SUBSTITUTED PIPERIDINES THAT INCREASE p53 ACTIVITY AND THE USES THEREOF |
| WO2011163330A1 (en) | 2010-06-24 | 2011-12-29 | Merck Sharp & Dohme Corp. | Novel heterocyclic compounds as erk inhibitors |
| CA2805265A1 (en) | 2010-08-02 | 2012-02-09 | Merck Sharp & Dohme Corp. | Rna interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (ctnnb1) gene expression using short interfering nucleic acid (sina) |
| WO2012024170A2 (en) | 2010-08-17 | 2012-02-23 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS B VIRUS (HBV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| US8883801B2 (en) | 2010-08-23 | 2014-11-11 | Merck Sharp & Dohme Corp. | Substituted pyrazolo[1,5-a]pyrimidines as mTOR inhibitors |
| US8946216B2 (en) | 2010-09-01 | 2015-02-03 | Merck Sharp & Dohme Corp. | Indazole derivatives useful as ERK inhibitors |
| EP2615916B1 (en) | 2010-09-16 | 2017-01-04 | Merck Sharp & Dohme Corp. | Fused pyrazole derivatives as novel erk inhibitors |
| WO2012058210A1 (en) | 2010-10-29 | 2012-05-03 | Merck Sharp & Dohme Corp. | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACIDS (siNA) |
| WO2012087772A1 (en) | 2010-12-21 | 2012-06-28 | Schering Corporation | Indazole derivatives useful as erk inhibitors |
| JP2014514321A (en) | 2011-04-21 | 2014-06-19 | メルク・シャープ・アンド・ドーム・コーポレーション | Insulin-like growth factor 1 receptor inhibitor |
| US9023865B2 (en) | 2011-10-27 | 2015-05-05 | Merck Sharp & Dohme Corp. | Compounds that are ERK inhibitors |
| US20150299696A1 (en) | 2012-05-02 | 2015-10-22 | Sirna Therapeutics, Inc. | SHORT INTERFERING NUCLEIC ACID (siNA) COMPOSITIONS |
| WO2014052563A2 (en) | 2012-09-28 | 2014-04-03 | Merck Sharp & Dohme Corp. | Novel compounds that are erk inhibitors |
| MX363243B (en) | 2012-11-28 | 2019-03-14 | Merck Sharp & Dohme | Compositions and methods for treating cancer. |
| RU2690663C2 (en) | 2012-12-20 | 2019-06-05 | Мерк Шарп И Доум Корп. | Substituted imidazopyridines as hdm2 inhibitors |
| US9540377B2 (en) | 2013-01-30 | 2017-01-10 | Merck Sharp & Dohme Corp. | 2,6,7,8 substituted purines as HDM2 inhibitors |
| US20160194368A1 (en) | 2013-09-03 | 2016-07-07 | Moderna Therapeutics, Inc. | Circular polynucleotides |
| US10947234B2 (en) | 2017-11-08 | 2021-03-16 | Merck Sharp & Dohme Corp. | PRMT5 inhibitors |
| WO2020033284A1 (en) | 2018-08-07 | 2020-02-13 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
| EP3833668A4 (en) | 2018-08-07 | 2022-05-11 | Merck Sharp & Dohme Corp. | Prmt5 inhibitors |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0411150B1 (en) * | 1989-02-10 | 1996-11-27 | Otsuka Pharmaceutical Co., Ltd. | Indole derivatives, preparation thereof, and drug for preventing and treating nephritis containing same |
| IL111730A (en) * | 1993-11-29 | 1998-12-06 | Fujisawa Pharmaceutical Co | Piperazine derivatives processes for the preparation thereof and pharmaceutical compositions containing the same |
-
1996
- 1996-05-21 WO PCT/JP1996/001335 patent/WO1996037489A1/en not_active Application Discontinuation
- 1996-05-21 AU AU57031/96A patent/AU706021B2/en not_active Ceased
- 1996-05-21 CN CN96195744A patent/CN1072220C/en not_active Expired - Fee Related
- 1996-05-21 CA CA002222041A patent/CA2222041A1/en not_active Abandoned
- 1996-05-21 NZ NZ307625A patent/NZ307625A/en unknown
- 1996-05-21 EA EA199700425A patent/EA000669B1/en not_active IP Right Cessation
- 1996-05-21 EP EP96915200A patent/EP0846116A1/en not_active Ceased
- 1996-05-21 HU HU9900822A patent/HUP9900822A3/en unknown
- 1996-05-21 KR KR1019970708331A patent/KR19990021857A/en not_active Application Discontinuation
- 1996-05-21 JP JP8535553A patent/JP3071829B2/en not_active Expired - Fee Related
- 1996-05-22 ZA ZA964101A patent/ZA964101B/en unknown
- 1996-05-22 IL IL11836996A patent/IL118369A/en active IP Right Grant
- 1996-05-23 TW TW085106105A patent/TW391960B/en not_active IP Right Cessation
- 1996-05-24 TR TR96/00438A patent/TR199600438A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU5703196A (en) | 1996-12-11 |
| WO1996037489A1 (en) | 1996-11-28 |
| CA2222041A1 (en) | 1996-11-28 |
| AU706021B2 (en) | 1999-06-03 |
| TR199600438A2 (en) | 1996-12-21 |
| EA000669B1 (en) | 2000-02-28 |
| JPH11505830A (en) | 1999-05-25 |
| JP3071829B2 (en) | 2000-07-31 |
| CN1072220C (en) | 2001-10-03 |
| HUP9900822A2 (en) | 1999-06-28 |
| EP0846116A1 (en) | 1998-06-10 |
| NZ307625A (en) | 1999-02-25 |
| HUP9900822A3 (en) | 1999-11-29 |
| CN1191533A (en) | 1998-08-26 |
| TW391960B (en) | 2000-06-01 |
| ZA964101B (en) | 1996-07-29 |
| EA199700425A1 (en) | 1998-12-24 |
| KR19990021857A (en) | 1999-03-25 |
| IL118369A0 (en) | 1996-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL118369A (en) | (2R)-1-¬3,5-bis(trifluoromethyl)benzoyl¾-2-(1H-indol-3-YL-methyl)-4-¬N-(4-methyl-1-piperazinyl)carbamoylmethyl¾-piperazine processes for its preparation and pharmaceutical compositions containing same | |
| GR3031526T3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same | |
| HUP9901159A3 (en) | Substituted benzylaminopiperidine derivatives and use thereof, pharmaceutical compositions containing these compounds | |
| HK1017895A1 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same | |
| HUP9700709A3 (en) | 1,2-diphenylpyrrole derivatives, use thereof and pharmaceutical compositions containing these compounds | |
| IL113389A0 (en) | 1,4-Benzodiazepine compounds, pharmaceutical compositions containing them, their preparation and use | |
| HUP9603495A2 (en) | 1-phenyl-2-dimethylaminomethyl-cyclohexan-1-ol-compounds, pharmaceutical compositions containing the same and process for their preparation | |
| HUP9901243A3 (en) | Quinazoline derivatives, preparation and use thereof, pharmaceutical compositions containing these compounds | |
| HUP9800792A3 (en) | Benzylpiperidines and piperazines, their use and pharmaceutical compositions containing the same | |
| IL117349A0 (en) | N-(3-benyofuranyl) urea-derivatives their preparation and pharmaceutical compositions containing them | |
| HUP9801880A3 (en) | Novel cryptophycins, their use and pharmaceutical compositions containing them | |
| GR3033591T3 (en) | Novel taxoids, preparation thereof, and pharmaceutical compositions containing same | |
| HUP9901485A2 (en) | Heterocyclylcarboxamide derivatives, pharmaceutical compositions containing the same, process for their preparation and their use | |
| HUP9801386A3 (en) | Indazolecarboxamide derivatives, preparation thereof and pharmaceutical compositions containing them | |
| IL113366A0 (en) | 1,5-benzodiazepine compounds, their preparation and use, and pharmaceutical compositions containing them | |
| HUP9902425A3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same | |
| GR3034203T3 (en) | Novel taxoids, preparation thereof, and pharmaceutical compositions containing same | |
| HU9503366D0 (en) | Novel n-arylaliphatic-n-alkyl-functionalised amides, method for their preparation and pharmaceutical compositions containing same | |
| HUP9601680A3 (en) | Benzisothiazolyl-substituted aminomethyl-chromanes, pharmaceutical compositions containing the same, process for their preparation and use of the compounds | |
| HUP9901349A3 (en) | Oxazolidinone derivatives, their preparation and pharmaceutical compositions containing these compounds | |
| HUP9801068A3 (en) | 1,2,3,4-tetrahydro-2-naphtaleneamine derivatives, process for their preparation, their use, and pharmaceutical compositions containing them | |
| HUP9802571A3 (en) | Pyridiniminyl-1,2-benzisoxazoles and- benzisothiazoles, process for their preparation and pharmaceutical compositions containing them | |
| IL118007A0 (en) | Isoxazoline compounds pharmaceutical compositions containing them and their use | |
| IL124415A (en) | N, n'-bridged bisindolylmaleimides, their preparation and pharmaceutical compositions containing them | |
| GR3036411T3 (en) | Novel taxoids, preparation thereof and pharmaceutical compositions containing same |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| HC | Change of name of proprietor(s) |